Back

Results - Announcements

Sales rise 20.76% to Rs 25.19 crore

Novelix Pharmaceuticals standalone net profit rises 405.56% in the March 2026 quarter

30-May-2026, 09:26
Net profit of Novelix Pharmaceuticals rose 405.56% to Rs 0.91 crore in the quarter ended March 2026 as against Rs 0.18 crore during the previous quarter ended March 2025. Sales rose 20.76% to Rs 25.19 crore in the quarter ended March 2026 as against Rs 20.86 crore during the previous quarter ended March 2025.

For the full year,net profit rose 3100.00% to Rs 2.56 crore in the year ended March 2026 as against Rs 0.08 crore during the previous year ended March 2025. Sales rose 330.70% to Rs 132.31 crore in the year ended March 2026 as against Rs 30.72 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	25.19	20.86	21	132.31	30.72	331
OPM %	5.08	1.10	-	2.63	0.46	-
PBDT	1.28	0.23	457	3.51	0.16	2094
PBT	1.23	0.21	486	3.41	0.12	2742
NP	0.91	0.18	406	2.56	0.08	3100